News & Updates
Filter by Specialty:
Pooled analysis ASSUREs seladelpar role in PBC
Results of the phase III ASSURE study support seladelpar – a novel first-in-class delpar (selective peroxisome proliferator-activated receptor delta agonist) – for the treatment of primary biliary cholangitis (PBC).
Pooled analysis ASSUREs seladelpar role in PBC
04 Dec 2024
Alcoholic drinks up risk of death in young adults with MASLD
Young adults with metabolic dysfunction-associated steatotic liver disease (MASLD) who drink alcoholic beverages are at greater risk of mortality and of having an unhealthy liver, reports a study presented at AASLD 2024.
Alcoholic drinks up risk of death in young adults with MASLD
26 Nov 2024
No level of alcohol intake is safe in MASLD patients, says study
Even modest alcohol consumption is associated with a higher risk of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), according to a study.
No level of alcohol intake is safe in MASLD patients, says study
25 Nov 2024
Is ChatGPT ready to give CRC screening recommendations?
The performance of ChatGPT in determining appropriate colorectal cancer (CRC) screening recommendations is relatively poor, with inconsistent responses in several questions, reports a study.
Is ChatGPT ready to give CRC screening recommendations?
20 Nov 2024
Retrograde colonic enema-based FMT safe, effective in childhood constipation
Fecal microbiota transplantation (FMT) can complement the use of retrograde colonic enema (RCE) in the treatment of children with intractable constipation, suggests a study.